(Q35042912)

6 August 2017

1 reference

title

Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis (English)

1 reference

6 August 2017

0 references

1 reference

Jean-François Dhainaut

series ordinal

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

The American Journal of Surgery

6 August 2017

published in

1 reference

6 August 2017

volume

184

1 reference

6 August 2017

issue

6A Suppl

1 reference

6 August 2017

page(s)

S5-10

1 reference

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

The sirens' songs of confirmatory sepsis trials: selection bias and sampling error.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Toll-like receptors in the induction of the innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Role of the coagulation system in the local and systemic inflammatory response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Review: infectious diseases and coagulation disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Pathogenetic mechanisms of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Activation of coagulation after administration of tumor necrosis factor to normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Sepsis/septic shock: participation of the microcirculation: an abbreviated review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: microscopic observation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Sepsis: a new hypothesis for pathogenesis of the disease process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Sepsis and septic shock: pro-inflammatory or anti-inflammatory state?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Cytokines and anticytokines in the pathogenesis of sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Time course of hemostatic abnormalities in sepsis and its relation to outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Epidemic meningococcemia and purpura fulminans with induced protein C deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Low levels of protein C are associated with poor outcome in severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Hepatic response to sepsis: interaction between coagulation and inflammatory processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Modulation of human endothelial thrombomodulin by neutrophils and their release products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Endothelial cell protein C receptor plays an important role in protein C activation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

Efficacy and safety of recombinant human activated protein C for severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901137-6

10.1016/S0002-9610(02)01137-6

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference